Veikko Salomaa
Salomaa, Veikko, 1950-
Salomaa, Veikko
VIAF ID: 12294715 (Personal)
Permalink: http://viaf.org/viaf/12294715
Preferred Forms
- 100 1 _ ‡a Salomaa, Veikko
- 100 1 _ ‡a Salomaa, Veikko, ‡d 1950-
- 100 0 _ ‡a Veikko Salomaa
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass | |
Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | |
Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. | |
European lactase persistence genotype shows evidence of association with increase in body mass index | |
Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield. | |
Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study. | |
Evening types are prone to depression | |
Evidence of inbreeding depression on human height | |
Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology | |
Exome-wide association study of plasma lipids in >300,000 individuals | |
An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease | |
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure | |
Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997 | |
Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression | |
Fine-Scale Genetic Structure in Finland | |
FINEMAP: efficient variable selection using summary data from genome-wide association studies | |
Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects | |
Forty-year trends in cardiovascular risk factors in Finland | |
Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging | |
Further Evidence For the Role ofENPP1in Obesity: Association With Morbid Obesity in Finns | |
Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey | |
Gender differences in the treatment and secondary prevention of CHD at population level | |
Genetic analysis of over one million people identifies 535 novel loci for blood pressure | |
Genetic architecture of human plasma lipidome and its link to cardiovascular disease | |
Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis | |
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization | |
Genetic causal beliefs about morbidity: associations with health behaviors and health outcome beliefs about behavior changes between 1982-2002 in the Finnish population | |
Genetic evidence of assortative mating in humans | |
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci | |
Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles | |
Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts | |
Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease | |
Genetic studies of body mass index yield new insights for obesity biology | |
Genetic support for the causal role of insulin in coronary heart disease | |
Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis. | |
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk | |
Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population | |
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile | |
Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes | |
Genetically determined height and coronary artery disease | |
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders | |
Genome-wide analysis identifies 12 loci influencing human reproductive behavior | |
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations | |
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits | |
Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity | |
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure | |
Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent | |
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants | |
Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. | |
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci | |
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction | |
Genome-wide association study identifies seven novel loci associating with circulating cytokines and cell adhesion molecules in Finns: | |
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure | |
Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population. | |
Genome-wide association study of white-coat effect in hypertensive patients | |
Genome-wide meta-analysis of common variant differences between men and women | |
Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults | |
Genome-wide scan of job-related exhaustion with three replication studies implicate a susceptibility variant at the UST gene locus | |
Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits | |
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. | |
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility | |
A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors | |
An immune response network associated with blood lipid levels | |
An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia | |
An interaction map of circulating metabolites, immune gene networks, and their genetic regulation | |
A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk | |
A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals | |
A metabolic view on menopause and ageing | |
A multiple biomarker risk score for guiding clinical decisions using a decision curve approach. | |
A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape | |
A reference panel of 64,976 haplotypes for genotype imputation | |
Sepelvaltimotaudin esiintyvyys Suomessa 1991-1994 : the occurrence of coronary heart disease in Finland 1991-1994 | |
Sydän- ja verisuonitautien ennaltaehkäisytoimen vaikutus vaaratekijäkehitykseen pitkän aikavälin seurannassa keski-ikäisillä miehillä, 1988: |